Shen Changyu, Li Xiaochun, Li Lingling
Department of Biostatistics, School of Medicine, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, U.S.A.
Stat Med. 2014 Feb 20;33(4):555-68. doi: 10.1002/sim.5969. Epub 2013 Sep 9.
Covariate adjustment in randomized clinical trials has the potential benefit of precision gain. It also has the potential pitfall of reduced objectivity as it opens the possibility of selecting a 'favorable' model that yields strong treatment benefit estimate. Although there is a large volume of statistical literature targeting on the first aspect, realistic solutions to enforce objective inference and improve precision are rare. As a typical randomized trial needs to accommodate many implementation issues beyond statistical considerations, maintaining the objectivity is at least as important as precision gain if not more, particularly from the perspective of the regulatory agencies. In this article, we propose a two-stage estimation procedure based on inverse probability weighting to achieve better precision without compromising objectivity. The procedure is designed in a way such that the covariate adjustment is performed before seeing the outcome, effectively reducing the possibility of selecting a 'favorable' model that yields a strong intervention effect. Both theoretical and numerical properties of the estimation procedure are presented. Application of the proposed method to a real data example is presented.
随机临床试验中的协变量调整具有提高精度的潜在益处。它也存在降低客观性的潜在风险,因为这增加了选择一个能得出显著治疗效果估计的“有利”模型的可能性。尽管有大量统计学文献关注第一个方面,但能确保客观推断并提高精度的切实可行的解决方案却很少见。由于一个典型的随机试验需要考虑许多超出统计范畴的实施问题,从监管机构的角度来看,保持客观性即便不比提高精度更重要,至少也是同等重要的。在本文中,我们提出一种基于逆概率加权的两阶段估计程序,以在不影响客观性的前提下实现更高的精度。该程序的设计方式使得协变量调整在观察到结果之前进行,有效地降低了选择一个能得出显著干预效果的“有利”模型的可能性。我们给出了估计程序的理论和数值特性。还展示了所提出方法在一个实际数据例子中的应用。